Aims The coronavirus disease 2019 (COVID‐19) pandemic has led to changes in health
care utilization for different acute cardiovascular diseases. Whether hospitalization rates and …

Background We sought to compare cardiovascular outcomes, renal function, and diuresis in
patients receiving standard diuretic therapy for acute heart failure (AHF) with or without the …

Objectives The aim of this study was to evaluate the interaction between hospital
endovascular lower extremity revascularization (eLER) volume and outcomes after eLER for …

Background Acute heart failure (HF) is a significant cause of readmission and mortality,
particularly within 30 days post-discharge. The interplay between COVID-19 and HF is still …

Background Peripheral artery disease (PAD) and microvascular disease (MVD) are highly
prevalent conditions that share common risk factors. This observational study aimed to …

Background Outcomes commonly used to ascertain success of metastatic spine tumour
surgery (MSTS) are 30-day complications/mortality and overall/disease-free survival. We …

Pulmonary infection is common in patients with heart failure, yet the risk factors remain
unclear. We aimed to evaluate the clinical characteristics and risk factors of pulmonary …

Transcatheter aortic valve implantation (TAVI) has become the mainstream treatment for
severe aortic stenosis. Despite improvement in device iteration and operator experience …

The HEFESTOS scale was developed in 14 Spanish primary care centres and validated in 9
primary care centres of other European countries. It showed good performance to predict …

Aims Reducing preventable hospitalization for congestive heart failure (CHF) patients is a
challenge for health systems worldwide. CHF patients who also have a recent or ongoing …